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Abstract
Background
Clinical diagnosis of Buruli ulcer (BU) due toMycobacterium ulcerans can be challenging.
We aimed to specify the differential diagnosis of skin lesions in a BU endemic area.
Method
We conducted a prospective diagnostic study in Akonolinga, Cameroon. Patients present-
ing with a skin ulcer suspect of BU were included.M. ulcerans was detected using swabs
for Ziehl-Neelsen staining, PCR and culture. Skin punch biopsies were taken and reviewed
by two histopathologists. Photographs of the lesions were taken and independently
reviewed by two dermatologists. Final diagnosis was based on consensus, combining the
results of laboratory tests and expert opinion.
Results/ Discussion
Between October 2011 and December 2013, 327 patients with ulcerative lesions were
included. Median age was 37 years (0 to 87), 65% were males, and 19% HIV-positive. BU
was considered the final diagnosis for 27% of the lesions, 85% of which had at least one
positive laboratory test. Differential diagnoses were vascular lesions (22%), bacterial infec-
tions (21%), post-traumatic (8%), fistulated osteomyelitis (6%), neoplasia (5%), inflamma-
tory lesions (3%), hemopathies and other systemic diseases (2%) and others (2%). The
proportion of BU was similar between HIV-positive and HIV-negative patients (27.0% vs.
26.5%; p = 0.940). Half of children below 15 years of age were diagnosed with BU, com-
pared to 26.8% and 13.9% among individuals 15 to 44 years of age and above, respectively
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(chi2 p<0.001). Children had more superficial bacterial infections (24.3%) and osteomyelitis
(11.4%).
Conclusion
We described differential diagnosis of skin lesions in a BU endemic area, stratifying results
by age and HIV-status.
Author Summary
In some areas of Africa, Australia or Japan, a specific skin infection presents as a wound
which progressively increases in size in children and people of any age. The agent which
causes this infection is namedMycobacterium ulcerans, close to the tuberculosis agent.
This wound, also named Buruli ulcer (BU), may be confused with other common cutane-
ous diseases. During two years in Akonolinga, Cameroon, we evaluated the wounds of all
patients who presented with suspected BU. This wound presentation was most frequently
recorded in young children and males. Buruli ulcer was indeed the most frequent diagnosis
in this area. However, with the help of laboratory and radiological techniques, we found
that many of those patients not diagnosed with BU were suffering from: vascular insuffi-
ciency (older persons), benign superficial infections and bone infections (children). This
observation is important and should help improve the diagnosis and treatment of patients
with skin ulcers in Africa.
Introduction
Infection byM. ulcerans, more commonly known as Buruli Ulcer (BU), is a neglected tropical
disease that has been reported in33 countries in Africa, the Americas, Asia and the Western
Pacific [1]. West Africa has the highest number of cases, found mainly in Benin, Cameroon,
Côte d’Ivoire, Democratic Republic of the Congo, and Ghana.M. ulcerans infection generally
begins with a localised, itchy skin lesion which evolves into localized (nodule) or diffuse
(oedema) swelling, or as an indurated plaque. Over time, the lesions progressively develop into
craters that result in potentially massive ulcers with undermined edges. Without proper treat-
ment, the scarring process can lead to contracture deformities and movement limitations.
[2, 3]
The laboratory technique most commonly used in the field for BU diagnosis is direct exami-
nation by microscopy using a Ziehl-Neelsen (ZN) stained smear in search of Alcohol- and
Acid-Fast bacilli, with a sensitivity of ZN of approximately 40% [4, 5]. The same staining tech-
nique can also be used for non-ulcerated plaques using fine needle aspiration [6]. Culture ofM.
ulcerans is a procedure with a sensitivity rate of 20–60% [5]. Polymerase Chain Reaction for
insertion sequence IS2404 is very specific and currently the most sensitive diagnostic method
with a sensitivity of 85% [7]. Histopathology is rarely used in the field, as the method requires
adapted tools for sample collection as well as specific knowledge to both prepare and interpret
the slides.
Cases of painless ulcerated plaques with undermined edges, classically described as BU [1],
are believed to be relatively easy to clinically diagnose in endemic regions; the difficulty lies in
diagnosing lesions in their early stages or when located in parts of the body where vascular
ulcers are also common. In a retrospective study carried out in Ghana, the specificity of clinical
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diagnosis was estimated to be 94% [8]. Nevertheless, without laboratory testing to confirm the
findings, diagnostic errors are probably highly under-estimated.
Various forms of BU can be mistaken for other types of ulcers found in tropical areas.
Among the most common are vascular or diabetic ulcers, drepanocytosis, yaws, ecthyma, pha-
gedenic ulcers, chronic herpes or all other infectious ulcers, as well as skin cancers [9, 10]. The
differential clinical diagnosis should also be broken down into age groups. For example, vascu-
lar ulcers are rare in children. For ulcer descriptions, most differential diagnoses proposed are
based on single expert opinions and are rarely based on actual data from prospective studies
[11]. Skin ulcers were infrequently seen in studies in Nigeria and Ethiopia which described the
principle causes of skin problems presenting at dermatological consultation and within house-
holds [12, 13]. We aimed to describe the differential diagnoses for lesions with suspectM.
ulcerans infection in central Cameroon.
Methods
In Cameroon, cases ofM. ulcerans infection have been reported in 8 regions, namely Ada-
mawa, Centre, East, Far North, North West, West, South, and South West. The Akonolinga
and the Ayos health districts located along the Nyong River were the first endemic foci
described in the country [14]. In 2002 Médecins Sans Frontières, in collaboration with the Min-
istry of Health, began treating BU in the Akonolinga Health District, where the overall BU
prevalence was 0.47% in 2007 [15].
Between 2011 and 2013, a prospective cohort study was conducted in Akonolinga Health
District, central Cameroon. All individuals presenting at Akonolinga District Hospital with a
skin lesion suspect of new BU (defined as nodule, plaque, localized swelling and/or an ulcer in
an individual residing in or having spent at least one night in a knownM. ulcerans endemic
area were enrolled consecutively after written consent. Patients who reported previous medical
or surgical treatment for BU were excluded. Clinical data and clinicians’ judgment on likeli-
hood of BU (using a semi-quantitative scale with four levels: BU very likely, likely, possible,
unlikely) were collected, before the results of laboratory examination were available. One expe-
rienced dermatologist from Yaounde Central Hospital visited the project every two weeks and
saw a subset of the patients. Photographs were taken of all suspect lesions. Photographs were
independently reviewed by two dermatologists: the first from Yaounde Central Hospital and
the second, experienced in tropical skin diseases from Geneva University Hospitals (Geneva,
Switzerland). Skin biopsies were also independently reviewed by two histopathologists one in
Yaounde and one in Geneva, respectively.
Dry swabs from ulcerative lesions and fine-needle aspirates of non-ulcerative lesions were
examined after ZN staining in Akonolinga Hospital laboratory the day they were collected.
Another set of samples was sent to the reference laboratory in Yaounde (Centre Pasteur Cam-
eroon, CPC) weekly, where, after pooling of the samples for each lesion, ZN direct examination
was repeated, followed by PCR targeting IS2404 and culture. The CPC is part of a BU external
quality control program run by the Institute of Tropical Medicine in Antwerp, Belgium. Two 4
mm punch skin biopsies were performed on ulcerative lesions, one at the edge and one in the
center of the lesion. Biopsies were stored in 4% formaldehyde before being sent weekly to
Yaounde (CPC), where slides were prepared for histopathological examination. Slides were sys-
tematically stained with hematoxylin/eosin and Ziehl-Neelsen. After a first examination in
Yaounde, the slides and remaining paraffin block were sent to Geneva University Hospitals,
where another reading took place.
Patients were screened for diabetes by a rapid test for plasma glucose, and for syphilis and
yaws by a rapid syphilis test (SD Bioline). HIV testing was systematically proposed to all
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patients, after counseling. Suspect cases of sickle cell disease were tested by Emmel test and
confirmed by haemoglobin electrophoresis in CPC. Patients were transferred to Yaounde for
radiographs for those starting specific Buruli treatment, and for those with suspect osteomyeli-
tis. Vascular examination through Doppler ultrasound was available in Yaounde, and was per-
formed in case of suspicion of a vascular origin to the lesion.
Cases without a definite diagnosis after initial evaluation by the two dermatologists were
discussed in consensus meetings that took place by videoconference between Yaounde and
Geneva with participation of clinicians, histopathologists and dermatologists. During these
meetings, all clinical information, laboratory results and wound evolution were reviewed for
specific cases. Clinicians were asked to estimate the probability of BU on a scale from 0 to 10 (0
being null probability of BU and 10 being total certainty). A final diagnosis of BU named “con-
sensus diagnosis” was defined as either: at least two positive tests among ZN done in Akono-
linga, ZN or PCR in CPC, positive acid-fast bacilli (AFB) on histology; being the most likely
diagnosis based on both expert reviews of photographs; or BU agreed upon as the most likely
diagnosis during consensus meetings. While the main objective of these meetings was to differ-
entiate BU from non-BU cases, final diagnoses of non-BU cases were also reviewed and agreed
upon.
Statistical analysis was performed using Stata/SE 12.1 (College Station, USA). Final diagno-
sis was described for all lesions, and according to sex, age, and HIV-status. Frequencies by cate-
gory were compared by chi-square test and results given with p-value. Final diagnoses were
regrouped into predefined diagnostic categories agreed upon by the dermatologists. Results
presented in this paper are restricted to diagnosis of ulcerative lesions, which represented the
majority of cases.
Ethics Statement
Ethical approval was given by the National Ethics Committee of Cameroon, the Central Com-
mission on Human Subject Research Ethics of the Geneva University Hospital, and the Ethical
Review Board of Médecins Sans Frontières. The study was also approved by the Ministry of
Health, in the framework of the National Yaws, Leishmaniasis, Leprosy and Buruli Control
Program, as well as by the health authorities of the Akonolinga District and Hospital adminis-
tration. All patients included in the study provided informed written consent; parents/guard-
ians provided consent on behalf of their children if participants were under the age of 18.
Results
Between October 2011 and December 2013, 447 patients were screened and 367 included in
the study. 364 were included in the final analysis (3 secondary exclusions due to missing clini-
cal data), corresponding to 422 lesions. Of the 80 cases not included, 50 had skin lesions not
suspect of BU, 26 had already been previously treated for Buruli ulcer, 3 did not consent, and
one was lost-to-follow-up (left the hospital) before completing screening.
The majority of patients (327/364 = 89.8%) presented with ulcerative lesions (Fig 1). The
median age of patients with ulcers was 37 years (range 0 to 87) and 213 (65%) were males.
According to WHO classification of ulcer severity, patients were of category I, II or III in
33.6%, 40.1% and 26.3% of cases, respectively.
The median symptom duration was 24 weeks (IQR 5 to 104 weeks, or 1 month to 2 years).
More than half of the patients had already received traditional (57.8%), topical (65.1%) or sys-
temic (68.5%) treatments for their lesions. A history of trauma, mainly previous injury, was
mentioned by 118 (36.1%). Patients were aware of another Buruli case in their village in121
(37.0%) cases, including 42 (34.7%) who lived under the same roof as a known case. Patient
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characteristics and exposure history are shown in Table 1. On clinical examination, 31 (9.5%)
had an axillary temperature above 37.5°C. Vascular examination was abnormal in 70 (21.3%)
of the patients, the most frequently described anomalies were venous insufficiency (39/
70 = 55.7%) followed by mixed insufficiency (24.3%), arterial insufficiency (10.0%), and others
or not specified (10.0%).
Sixty-three patients (19.3%) were HIV-positive (the 7 not tested and one with a discordant
result were considered HIV-negative), with a median CD4 count of 362 (IQR 210–653; 12
missing CD4 count). Hypertension was confirmed in only 4 cases (1.2%) and suspected in
another 9 (2.8%). Diabetes was suspected in 22 (6.7%) and confirmed 7 (2.1%) cases, respec-
tively. Sickle cell disease was confirmed in 6 (1.8%) patients. Rapid syphilis test was positive in
48/327 patients (14.7%) overall, 5.9% (4/68; 2 missing) among children under 15 years and
17.4% (44/253; 4 missing) among adults. Of the patients with a positive rapid test, 39 were fur-
ther tested with TPHA and VDRL. Three patients had a positive VDRL and TPHA, all were
older than 15 years of age. Ten were negative for both VDRL and TPHA, including the 4 chil-
dren, likely indicating a false positive rapid test. 26 were VDRL negative and TPHA positive,
reflecting an old infection.
Clinician 1 saw 160 lesions, clinician 2 evaluated 230 other lesions and dermatologist in the
field saw 218 lesions. The two dermatologists gave their opinion on 327 lesions.M ulcerans was
judged very likely between 11.3% (18/160) and 31.3% (72/230) of patients with ulcerative
lesions according to the clinicians, 25.2% (55/218) of the patients seen by the dermatologist,
and 16.8% (55/327) and 26.9% (88/327) of the opinions given on photographs. Concordance of
clinical likelihood of BU and dermatological evaluation based on photographs graded in four
levels were poor (kappa = 0.25 and 0.20, respectively). Combining the four into two levels
(“very likely and likely” versus “possible and unlikely”) increased concordance to 0.46 and
0.40, respectively, with agreement in 64% and 72% of the cases, respectively. Laboratory tests
were positive for BU in 8.9% (29/327) of culture, 10.7% (35/327) and 17.7% (58/327) for ZN
Fig 1. Patient flow, Buruli score study 2011–2013, Akonolinga, Cameroon.
doi:10.1371/journal.pntd.0004385.g001
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done in Yaounde and Akonolinga, respectively, and 23.6% (77/327) for PCR. Apart from spe-
cific cases of neoplasia, histopathology was of little help when determining the final diagnosis,
with 37% (131/350) and 54% (187/350) lesions receiving histopathological diagnoses of non-
specific ulcers in Yaounde and Geneva, respectively.
Out of 327 patients, two thirds (219) could be classified as BU or non-BU based on the labo-
ratory test results and evaluations made on photographs. There was agreement on the final
diagnoses of the non-BU cases between the two independent dermatologists. The remaining
108 patients with 125 controversial lesions were discussed during eight consensus meetings,
attended by 3 to 6 clinicians, 2 dermatologists and 2 histopathologists. The mean BU probabil-
ity for lesions considered to be BU by the clinicians was 8.4 (SD 0.7), and 2.8 (SD 1.4) for those
considered non-BU. Discrepant non-BU diagnoses were also reviewed during these meetings.
M ulcerans was considered the final diagnosis by consensus in 26.6% (87/327) patients. Of
those, 74 (85.1%) were confirmed cases with at least one positive laboratory test (ZN, PCR or
culture). The second and third most frequently detected ulcers were venous ulcers (12.8%) fol-
lowed by superficial bacterial skin infections (ecthyma, impetigo, folliculitis, or boils) (11.9%).
Other frequent diagnoses (>5% of patients) were mixed vascular ulcers (6.7%), post-traumatic
(7.3%), erysipelas (6.4%), and osteomyelitis (5.8%). Sixteen patients (4.9%) had non-specific
ulcers that could not be attributed to a clear etiology. Seventeen cases of neoplasia were found.
Detailed diagnoses are shown in Table 2.
Table 1. Characteristics of patients’ history. Univariate analysis in patients with ulcerative lesions. Buruli score study 2011–2013, Akonolinga,
Cameroon.
Total (N = 327) BU (N = 87) Non-BU (N = 240)
n % n % n % p-value*
Median duration of present episode, in weeks (IQR) 23 (5–104) 12 (4–24) 36 (6–144) <0.001
Missing 7 0 7
Other treatments received:
Topical 213 65.1 49 56.3 164 68.3 0.044
Systemic 224 68.5 48 55.2 176 73.3 0.002
traditional 189 57.8 48 55.2 141 58.8 0.563
History of trauma 118 36.1 26 29.9 61 70.1 0.16
Type of trauma 0.841
Injury 53 45.7 11 42.3 42 46.7
Insect bite 11 9.5 3 11.5 8 8.9
Burn 13 11.2 2 7.7 11 12.2
Others 39 33.6 10 38.5 29 32.2
Missing 2
BU cases in the vicinity (1 missing) 121 37.0 40 46.0 81 33.8 0.043
Living in the same village 77 64.7 25 62.5 52 65.8
Living under the same roof 42 35.3 15 37.5 27 34.2
Missing 2
Median age, in years (IQR) 37 (18–56) 20 (10–34) 42 (23–57) <0.001
Gender 0.005
Male 213 65.1 46 52.9 167 69.6
Female 114 34.9 41 47.1 73 30.4
* p-value comparing BU and non-BU (ranksum test for continuous and chi2 for categorical variables)
doi:10.1371/journal.pntd.0004385.t001
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Table 2. Differential diagnosis of patients with ulcerative skin lesions, Buruli score study 2011–2013,
Akonolinga, Cameroon.
Diagnostic category (N = 327)
Detailed diagnosis n %
M ulcerans infection 87 26.6
Vascular and neuropathic ulcers
Subtotal 73 22.3
Venous ulcer 42 12.8
Mixed vascular ulcer* 22 6.7
Neuropathic ulcer 7 2.1
Arterial ulcer 1 0.3
Pressure sore 1 0.3
Bacterial infections
Subtotal 68 20.8
Ecthyma /impetigo/boils 39 11.9
Infectious dermohypodermatitis 21 6.4
Abcess 3 0.9
Necrotizing fasciitis 2 0.6
Phagedenic ulcer 2 0.6
Gum 1 0.3
Post-traumatic ulcers
Subtotal 25 7.6
Post-traumatic 24 7.3
Toxic necrosis 1 0.3
Osteomyelitis
Subtotal 19 5.8
Osteomyelitis 19 5.8
Neoplasia
Subtotal 17 5.2
Carcinoma* 7 2.1
Kaposi 7 2.1
Sarcoma 3 0.9
Inﬂammatory diagnoses
Subtotal 9 2.8
Vasculitis 5 1.5
Neutrophilic dermatosis (pyoderma gangrenosum) 2 0.6
Eczema 2 0.6
Hemopathies and other systemic diseases
Subtotal 8 2.4
Ulcer of hemopathies 7 2.1
Chronic oedema due to cardiac insufﬁciency 1 0.3
Benign disorders
Subtotal 2 0.6
Insect bite 1 0.3
Benign tumor 1 0.3
Non-bacterial infections
Subtotal 2 0.6
Oedema associated with parasite (ﬁlaria) 1 0.3
Herpes 1 0.3
(Continued)
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The proportion of BU was the same between HIV-positive and HIV-negative patients
(27.0% versus 26.5%; p = 0.940). HIV-positive patients were more likely to present with large
lesions (29.1% above 15 cm vs. 14.6% p = 0.01). Bacterial infections were more frequent among
HIV positive patients (34.9% vs. 17.4%; p = 0.002) while vascular or neuropathic ulcers (mainly
venous or mixed vascular ulcers) were more frequent among HIV-negative patients (25.0% vs.
17.4%; p = 0.017). Half of children under 15 years of age had BU, compared to 26.8% and
13.9% among patients 15 to 44 years of age and patients45 years of age, respectively
(p<0.001). Among children, other frequent diagnoses were superficial bacterial skin infections
(24.3%) and osteomyelitis (11.4%). When compared to BU, both vascular ulcers and bacterial
infections were more frequently reported among patients45 years old (40.0% and 19.2% vs.
13.9%; p< 0.001 and p = 0.081, respectively). Half of the vascular or neuropathic ulcers (36/73)
were confirmed by Doppler examination. The absolute numbers ofM ulcerans infections was
similar between males and females (46 vs. 41). However, because there were more males than
females included in the study (213 vs 114), when included, females had a higher chance of hav-
ing a lesion diagnosed as BU (36.0% vs. 21.6% for males; p = 0.005). Compared to females,
males more frequently presented with other causes of skin lesions, particularly all vascular
lesions (venous ulcers, hemopathies, vasculitis), as well as post-traumatic and osteomyelitis
(Table 3).
Discussion
We describe the differential diagnosis of Buruli ulcer in an area endemic forM. ulcerans, based
on prospectively collected data. The strength of our results is based on a rigorous consensus
approach that combines clinical diagnosis, laboratory tests and multiple expert opinion.
BU was not surprisingly the most frequent diagnosis for patients with ulcerative lesions that
were included in the study. The second most frequent diagnosis category was vascular lesions
(including neuropathic ulcers), followed by bacterial infections. Classical “tropical” diagnoses
such as drepanocytosis, phagedenic ulcer, yaws or leishmaniasis were quite rare. We did not
find any typical cutaneous yaws, although several treponemal tests were concomitantly positive
but only among adults. Phagedenic ulcers are known to be associated with mixed bacterial
infection and malnutrition [16, 17]. We did not observe malnutrition which could have led to a
larger number of tropical ulcers [18]. We were surprised by the high number of venous insuffi-
ciencies, while arterial insufficiency, and risk factors such as hypertension and diabetes were
Table 2. (Continued)
Diagnostic category (N = 327)
Detailed diagnosis n %
Fistulas
Subtotal 2 0.6
Abdominal ﬁstula 1 0.3
Anal ﬁstula 1 0.3
Non-speciﬁc ulcers
Subtotal 16 4.9
Non-speciﬁc ulcer 16 4.9
* One patient had two lesions with two different ﬁnal diagnoses (venous ulcer and squamous cell
carcinoma), counted in both categories
doi:10.1371/journal.pntd.0004385.t002
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rather uncommon unlike other settings in Africa [19, 20]. While common skin diseases seen in
northern countries have been described in Sub-Saharan Africa, vascular ulcers were curiously
not reported in the same studies [12,13]. Infectious complications of chronic ulcers such as cel-
lulitis or osteomyelitis may mask the underlying diagnosis, or patients with leg ulcers might
not seek specialized dermatological care and may be more likely to be followed in surgical con-
sultations, or do not seek care at all. Médecins Sans Frontières BU program started in 2005 in
Akonolinga, and provided tools for a global BU management including systemic antimicrobial
therapy, physiotherapy and local wound care. Thus patients have been encouraged to seek
treatment for wounds of different etiologies. This may have led to our great variety of diagno-
ses. In our cohort, age was the primary factor associated with vascular ulcers (Table 3), with a
large number of relatively young adult males suffering from venous insufficiency. We investi-
gated some of these ulcers by Doppler examination and morphological echography and often
found old venous thrombosis. Predisposing genetic factors or systemic auto-immune diseases
may be suspected.
Bacterial infections were common, especially among children and HIV-positive patients.
Non-BU related osteomyelitis were also common, and were confirmed by X-ray evaluation.
Most of them were clinically typical and were managed adequately. They were different from
BU associated osteomyelitis, which was usually associated with deep BU and confirmed by pos-
itive laboratory test for BU.
Interestingly, HIV was not found to be associated with BU diagnosis among patients with
skin lesions The overall HIV-prevalence (19%) appears higher than the prevalence in the gen-
eral population (6.1% in Centre region in 2011)[18]. Our data do not support the hypothesis
that HIV positivity is a risk factor for development of BU. However, as previously described,
HIV-positive patients did present with larger lesions when compared with HIV-negative
patients [21]. Patients with BU who were diagnosed with HIV received antiretroviral therapy
Table 3. Category of final diagnosis of patients with ulcerative skin lesions, by HIV status, age and gender, Buruli score study 2011–2013, Akono-
linga, Cameroon.
Total By age By gender By HIV status
Below 15 15 to 44 45 and
above
Male Female Positive Negative
or not
tested
(N = 327) (N = 70) (N = 127) (N = 130) (N = 213) (N = 114) (N = 63) (N = 264)
M ulcerans infection 87 26.6 35 50.0 34 26.8 18 13.9 46 21.6 41 36.0 17 27 70 26.5
Vascular and neuropathic ulcers* 73 22.3 1 1.4 20 15.8 52 40.0 56 26.3 17 14.9 7 11.1 66 25
Bacterial infections 68 20.8 17 24.3 26 20.5 25 19.2 38 17.8 30 26.3 22 34.9 46 17.4
Post-traumatic ulcers 25 7.7 4 5.7 9 7.1 12 9.2 20 9.4 5 4.4 3 4.8 22 8.3
Osteomyelitis 19 5.8 8 11.4 6 4.7 5 3.9 15 7.0 4 3.5 3 4.8 16 6.1
Neoplasia* 17 5.2 1 1.4 7 5.5 9 6.9 10 4.7 7 6.1 4 6.4 13 4.9
Inﬂammatory diagnoses 9 2.8 0 0.0 6 4.7 3 2.3 9 4.2 0 0.0 1 1.6 8 3
Hemopathies and other systemic diseases 8 2.5 1 1.4 6 4.7 1 0.8 7 3.3 1 0.9 0 0 8 3
Benign disorders 2 0.6 1 1.4 1 0.8 0 0.0 1 0.5 1 0.9 0 0 2 0.8
Non-bacterial infections 2 0.6 0 0.0 2 1.6 0 0.0 2 0.9 0 0.0 1 1.6 1 0.4
Fistulas 2 0.6 1 1.4 1 0.8 0 0.0 2 0.9 0 0.0 0 0 2 0.8
Non-speciﬁc ulcers 16 4.9 1 1.4 9 7.1 6 4.6 8 3.8 8 7.0 5 7.9 11 4.2
* One patient had two lesions with two different ﬁnal diagnoses (venous ulcer and squamous cell carcinoma), counted in both categories
doi:10.1371/journal.pntd.0004385.t003
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as soon as they were diagnosed. Tumors were confirmed in 5% of all lesions. Our results appear
to accurately reflect the cancer profile in Sub-Saharan Africa. Kaposi sarcoma was the most fre-
quently diagnosed cancer with 7 cases, including three HIV- positive patients. Although AIDS
associated Kaposi sarcoma is much better described, this data highlights the importance of
endemic African Kaposi sarcoma [22, 23]. We found five primary epidermoid (keratinizing or
not) carcinoma. In our cohort they did not complicate a Buruli ulcer. Any chronic wound is a
risk factor for such a carcinoma. This is well known for vascular wounds and was exceptionally
reported on Buruli ulcer [24, 25]. Histopathological analysis was crucial for confirmation of
such a diagnosis.
Our study has some limitations: we lacked agreement between laboratory test and clinical
diagnosis for several cases and we cannot exclude some diagnostic misclassification due to our
consensus approach. In particular, BU may have been over-diagnosed by the experts. However,
it was the most relevant approach to reach a final precise diagnosis for most cases, as shown by
the limited number of non-specific ulcers. Expert dermatological opinion by dermatologists
based on photographs, depends on the quality of photographs and is limited when compared
to clinical diagnosis. Traditional medicine products or any topical drug applied on a wound
just before sampling may have led to false negative results. Furthermore, secondary infection
may delay BU diagnosis by modifying clinical presentation. Follow- up is an important step in
clinical evaluation, but was not possible for several patients. The contribution of histopathology
to BU diagnosis was disappointing. We would suggest keeping a small punch biopsy for differ-
ential diagnosis of atypical or complex cases, only in collaboration with an experienced labora-
tory. Finally, we offered treatment to patients with confirmed BU and non-BU. When non-BU
management was severe and complex, for rare tumors or vasculitis, for example, patients who
found it difficult to understand the importance of additional investigations and treatment were
frequently lost to follow-up. Interestingly, we found that some other parameters that were
thought to be typical of Buruli were instead typical of vascular ulcers or bacterial infection.
Management of chronic wounds is usually challenging and requires a multidisciplinary
approach. Even in an endemic area the large majority of wounds are not associated with BU
and we advocate for a syndromic approach based on improved diagnosis and adapted treat-
ment for chronic wounds. A program and specific education for health care professionals on
chronic wound diagnosis and care has been reinforced in Cameroon [26].
Conclusion
We highlight the differential diagnosis of skin lesions in a Buruli endemic area of Cameroon.
Most skin lesions were not actually due toM ulcerans. Vascular and bacterial causes were very
common, while typically “tropical” diagnoses were rare. When making such diagnoses tumors
and osteomyelitis should not be overlooked. Age, sex and HIV status need to be taken into
account when assessing patients with skin lesions.
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